Skip to main content
logo
OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.520
-0.050 (-3.18%)
At close: Aug 11, 2026, 4:00 PM EDT
1.500
-0.020 (-1.32%)
After-hours: Aug 11, 2026, 5:07 PM EDT

OKYO Pharma Balance Sheet

Millions USD. Fiscal year is Apr - Mar.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
14.591.560.834.052.7
Short-Term Investments
6----
Cash & Short-Term Investments
20.591.560.834.052.7
Cash Growth
1219.38%88.78%-79.56%49.70%-60.78%
Other Receivables
0.382.110.711.151.6
Total Trade Receivables
0.382.110.711.151.6
Total Current Assets
20.973.681.545.24.3
Net Property, Plant & Equipment
0.01000.010.01
Total Assets
20.983.681.545.24.3

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
8.649.237.425.041.35
Short-Term Debt
---2.22-
Total Current Liabilities
8.649.237.427.261.35
Total Liabilities
8.649.237.427.261.35

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Additional Paid-in Capital
176.44148.95147.96135.1103.98
Accumulated Other Comprehensive Income
-12.13-11.47-11.31-11.45-0
Retained Earnings
-151.97-143.02-142.52-125.7-101.03
Shareholders' Equity
12.34-5.55-5.88-2.052.95
Total Liabilities & Equity
20.983.681.545.24.3

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
0002.220
Net Cash (Debt)
20.591.560.831.832.7
Net Cash Growth
1219.38%88.78%-54.82%-32.27%-60.58%
Net Cash Per Share
35.072.571.835.3411.66
Book Value
12.34-5.55-5.88-2.052.95
Book Value Per Share
21.00-9.13-13.02-6.0012.72
Tangible Book Value
12.34-5.55-5.88-2.052.95
Tangible Book Value Per Share
21.00-9.13-13.02-6.0012.72
SEC Filings: 10-K · 10-Q